[S-39] シンポジウム39
The concept of MOG-IgG positive diseases

[S-39-2] Clinical manifestation of MOG-IgG associated encephalomyelitis

^○Sung Min Kim (Seoul National University Hospital)

Auto-antibodies (IgG) against myelin oligodendrocyte glycoprotein (MOG) are detected in the serum of patients with various demyelinating diseases. These patients are known to show repeated clinical episodes of inflammatory demyelinating attacks in the central nervous system. Although the associated pathogenicity and mechanism of inflammatory demyelination remains inconclusive, it is known that patients with MOG-IgG have a different clinical spectrum from those with other demyelinating diseases, such as multiple sclerosis. We conducted this symposium to understand the clinical features and the spectrum of MOG-IgG related demyelinating diseases.

Dr Sung-Min Kim is an associate professor at the Department of Neurology of Seoul National University Hospital in Seoul, South Korea. He is also chair of the informatics committees of the Korean Society of Multiple Sclerosis and Korean Society of Clinical Neurophysiology.
Dr Kim completed his medical degree at Seoul National University in 2001. He completed his residency in the Department of Neurology of the same institution in 2006. In 2007, he pursued a master’s degree, followed by a fellowship in neuromuscular disorders in 2008. In 2010 he undertook a role as a visiting physician at the University of Chicago Medical Center, Chicago, IL, USA. Dr Kim became an assistant professor at Seoul National University Hospital in 2011, was awarded his PhD in 2014, and rose to the rank of associate professor in 2017.
Dr Kim’s primary research interests include multiple sclerosis, myelitis, optic neuritis, peripheral nerve disease, optic neuritis, and Bechet’s disease. He has published extensively on many of these research subjects and has conducted several phase III clinical trials of agents against neuromyelitis optica, amyotrophic lateral sclerosis, and multiple sclerosis.